pan-Ras inhibitor 3144
CAS No. 1835283-94-7
pan-Ras inhibitor 3144( Compound 3144 )
Catalog No. M12834 CAS No. 1835283-94-7
pan-Ras inhibitor 3144 (Compound 3144) is a multivalent small-molecule, pan-RAS inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 167 | Get Quote |
|
| 10MG | 260 | Get Quote |
|
| 25MG | 500 | Get Quote |
|
| 50MG | 713 | Get Quote |
|
| 100MG | 963 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namepan-Ras inhibitor 3144
-
NoteResearch use only, not for human use.
-
Brief Descriptionpan-Ras inhibitor 3144 (Compound 3144) is a multivalent small-molecule, pan-RAS inhibitor.
-
Descriptionpan-Ras inhibitor 3144 (Compound 3144) is a multivalent small-molecule, pan-RAS inhibitor with Kd of 4.7/17/6.6/3.7 uM for KRAS G12D/KRAS wt/HRAS/NRAS respectively; shows weak bindinf for RRAS2 (Kd=24 uM) and no activity for other small GTPases in the RAS superfamily; exhibits lethality in cells partially dependent on expression of RAS proteins; has suitable ADME properties and displays anti-tumor activity in xenograft mouse of pancreatic cancer; orally bioavailable.
-
In Vitro——
-
In Vivo——
-
SynonymsCompound 3144
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1835283-94-7
-
Formula Weight717.659
-
Molecular FormulaC36H41Cl2F3N6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL 69.67 mM
-
SMILESO=C(C1(N)CCNCC1)NCCCN2C=C(C3=CC=C(OC(F)(F)F)C=C3)C4=C2C=CC(CN5CCN(CC6=C(Cl)C=CC=C6Cl)CC5)=C4
-
Chemical Name4-amino-N-(3-(5-((4-(2,6-dichlorobenzyl)piperazin-1-yl)methyl)-3-(4-(trifluoromethoxy)phenyl)-1H-indol-1-yl)propyl)piperidine-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Welsch ME, et al. Cell. 2017 Feb 23;168(5):878-889.e29.
molnova catalog
related products
-
MRTX1133
MRTX1133 is a potent, selective, noncovalent KRASG12D inhibitor. It has picomolar binding affinity, single-digit nanomolar activity in cellular assays. In addition, it has significant in vivo efficacy in tumor models harboring KRASG12D mutations.
-
Antineoplaston A10(b...
Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
-
KRas-IN-1
A chemical fragment hit that binds to K-Ras (G12D) with affinities of 1.3-2 mM.
Cart
sales@molnova.com